263 related articles for article (PubMed ID: 25486994)
1. Impact of resolvin E1 on murine neutrophil phagocytosis in type 2 diabetes.
Herrera BS; Hasturk H; Kantarci A; Freire MO; Nguyen O; Kansal S; Van Dyke TE
Infect Immun; 2015 Feb; 83(2):792-801. PubMed ID: 25486994
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil Resolvin E1 Receptor Expression and Function in Type 2 Diabetes.
Freire MO; Dalli J; Serhan CN; Van Dyke TE
J Immunol; 2017 Jan; 198(2):718-728. PubMed ID: 27994073
[TBL] [Abstract][Full Text] [Related]
3. Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation.
El Kebir D; Gjorstrup P; Filep JG
Proc Natl Acad Sci U S A; 2012 Sep; 109(37):14983-8. PubMed ID: 22927428
[TBL] [Abstract][Full Text] [Related]
4. Resolvin E1 receptor activation signals phosphorylation and phagocytosis.
Ohira T; Arita M; Omori K; Recchiuti A; Van Dyke TE; Serhan CN
J Biol Chem; 2010 Jan; 285(5):3451-61. PubMed ID: 19906641
[TBL] [Abstract][Full Text] [Related]
5. Transcriptomics of type 2 diabetic and healthy human neutrophils.
Kleinstein SE; McCorrison J; Ahmed A; Hasturk H; Van Dyke TE; Freire M
BMC Immunol; 2021 Jun; 22(1):37. PubMed ID: 34134627
[TBL] [Abstract][Full Text] [Related]
6. RvE1 protects from local inflammation and osteoclast- mediated bone destruction in periodontitis.
Hasturk H; Kantarci A; Ohira T; Arita M; Ebrahimi N; Chiang N; Petasis NA; Levy BD; Serhan CN; Van Dyke TE
FASEB J; 2006 Feb; 20(2):401-3. PubMed ID: 16373400
[TBL] [Abstract][Full Text] [Related]
7. Resolvin E1 metabolome in local inactivation during inflammation-resolution.
Hong S; Porter TF; Lu Y; Oh SF; Pillai PS; Serhan CN
J Immunol; 2008 Mar; 180(5):3512-9. PubMed ID: 18292578
[TBL] [Abstract][Full Text] [Related]
8. Function of Pro-Resolving Lipid Mediator Resolvin E1 in Type 2 Diabetes.
Sima C; Paster B; Van Dyke TE
Crit Rev Immunol; 2018; 38(5):343-365. PubMed ID: 30806214
[TBL] [Abstract][Full Text] [Related]
9. RvE1 Attenuates Polymicrobial Sepsis-Induced Cardiac Dysfunction and Enhances Bacterial Clearance.
Chen J; Purvis GSD; Collotta D; Al Zoubi S; Sugimoto MA; Cacace A; Martin L; Colas RA; Collino M; Dalli J; Thiemermann C
Front Immunol; 2020; 11():2080. PubMed ID: 32983159
[TBL] [Abstract][Full Text] [Related]
10. Resolvin E1 Reduces Tumor Growth in a Xenograft Model of Lung Cancer.
Kantarci A; Kansal S; Hasturk H; Stephens D; Van Dyke TE
Am J Pathol; 2022 Oct; 192(10):1470-1484. PubMed ID: 35944728
[TBL] [Abstract][Full Text] [Related]
11. Resolvin D1, but not resolvin E1, transactivates the epidermal growth factor receptor to increase intracellular calcium and glycoconjugate secretion in rat and human conjunctival goblet cells.
Kaye R; Botten N; Lippestad M; Li D; Hodges RR; Utheim TP; Serhan CN; Dartt DA
Exp Eye Res; 2019 Mar; 180():53-62. PubMed ID: 30513286
[TBL] [Abstract][Full Text] [Related]
12. Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation.
Oh SF; Pillai PS; Recchiuti A; Yang R; Serhan CN
J Clin Invest; 2011 Feb; 121(2):569-81. PubMed ID: 21206090
[TBL] [Abstract][Full Text] [Related]
13. Lipoxin A(4) analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease.
Pouliot M; Clish CB; Petasis NA; Van Dyke TE; Serhan CN
Biochemistry; 2000 Apr; 39(16):4761-8. PubMed ID: 10769133
[TBL] [Abstract][Full Text] [Related]
14. Porphyromonas gingivalis-induced production of reactive oxygen species, tumor necrosis factor-α, interleukin-6, CXCL8 and CCL2 by neutrophils from localized aggressive periodontitis and healthy donors: modulating actions of red blood cells and resolvin E1.
Damgaard C; Kantarci A; Holmstrup P; Hasturk H; Nielsen CH; Van Dyke TE
J Periodontal Res; 2017 Apr; 52(2):246-254. PubMed ID: 27146665
[TBL] [Abstract][Full Text] [Related]
15. Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo.
Hasturk H; Kantarci A; Goguet-Surmenian E; Blackwood A; Andry C; Serhan CN; Van Dyke TE
J Immunol; 2007 Nov; 179(10):7021-9. PubMed ID: 17982093
[TBL] [Abstract][Full Text] [Related]
16. An endogenous regulator of inflammation, resolvin E1, modulates osteoclast differentiation and bone resorption.
Herrera BS; Ohira T; Gao L; Omori K; Yang R; Zhu M; Muscara MN; Serhan CN; Van Dyke TE; Gyurko R
Br J Pharmacol; 2008 Dec; 155(8):1214-23. PubMed ID: 18806821
[TBL] [Abstract][Full Text] [Related]
17. Effects of Endotoxin Tolerance Induced by Porphyromonas gingivalis Lipopolysaccharide on Inflammatory Responses in Neutrophils.
Gu JY; Liu YJ; Zhu XQ; Qiu JY; Sun Y
Inflammation; 2020 Oct; 43(5):1692-1706. PubMed ID: 32440987
[TBL] [Abstract][Full Text] [Related]
18. Combined administration of resolvin E1 and lipoxin A4 resolves inflammation in a murine model of Alzheimer's disease.
Kantarci A; Aytan N; Palaska I; Stephens D; Crabtree L; Benincasa C; Jenkins BG; Carreras I; Dedeoglu A
Exp Neurol; 2018 Feb; 300():111-120. PubMed ID: 29126887
[TBL] [Abstract][Full Text] [Related]
19. Resolvin E1, but not resolvins E2 and E3, promotes fMLF-induced ROS generation in human neutrophils.
Unno Y; Sato Y; Fukuda H; Ishimura K; Ikeda H; Watanabe M; Tansho-Nagakawa S; Ubagai T; Shuto S; Ono Y
FEBS Lett; 2018 Aug; 592(16):2706-2715. PubMed ID: 30069868
[TBL] [Abstract][Full Text] [Related]
20. Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferation.
Qu X; Zhang X; Yao J; Song J; Nikolic-Paterson DJ; Li J
J Pathol; 2012 Dec; 228(4):506-19. PubMed ID: 22610993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
